| Global Volumetric Assessment and Three-Dimensional Enhancement of the Face With Injectable Poly-L-lactic Acid. | |
| | |
MedLine Citation:
|
PMID: 20877539 Owner: NLM Status: In-Data-Review |
Abstract/OtherAbstract:
|
Nonsurgical methods represent the majority of cosmetic procedures performed in the United States and include the use of toxins and injectable medical devices for soft-tissue augmentation. In some cases, both nonsurgical and surgical modalities can be used synergistically for optimal facial rejuvenation. Aesthetic surgical procedures remove and reposition lax or sagging skin and tighten and/or resuspend facial musculature. Injectable medical devices can enhance the aesthetic effect of cosmetic surgery by replacing lost volume and restoring the three-dimensional appearance of the face while maintaining natural facial contours. Soft-tissue augmentation can also provide additional support for the skin, correcting natural variations in facial symmetry. This article provides a descriptive review of the age-related facial changes and suggests a method for the use of three-dimensional volumetric augmentation for soft-tissue facial rejuvenation. Age-related changes in skin elasticity, fat distribution, and facial contours require a three-dimensional treatment approach that addresses the pathophysiology of chronological aging. Volume replacement restores the youthful appearance of the face in patients opting for nonsurgical rejuvenation and complements surgical approaches as well. Optimal three-dimensional soft-tissue augmentation can be achieved using a combination of aesthetic surgery and injectable medical devices, such as collagen, hyaluronic acid, calcium hydroxylapatite, and injectable poly-L-lactic acid to improve facial volume changes and contour irregularities. Injectable medical devices replace lost volume and restore facial convexity, reestablishing the bloom of youth. |
| | |
Authors:
|
Richard N Sherman |
Related Documents
:
|
12180469 - Hazardous materials: revision to standards for infectious substances. final rule. 10179309 - Medical devices; refurbishers, rebuilders, reconditioners, servicers, and "as is" remar... 15926359 - And then there were three. with consolidation leaving three major players in each secto... 18084869 - Supraglottic devices: a possible role in prehospital toxic mass casualty event? 3859589 - Hydrogen sulfide and the probabilities of 'inhalation' through a tympanic membrane defect. 8215939 - Peracetic acid and its application to medical instrument sterilization. 10125549 - Reducing the volume of reports filed after discharge in the medical record department a... 12180469 - Hazardous materials: revision to standards for infectious substances. final rule. 6530299 - The cultural construction of aging and dying in a melanesian community. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: The Journal of clinical and aesthetic dermatology Volume: 3 ISSN: 1941-2789 ISO Abbreviation: J Clin Aesthet Dermatol Publication Date: 2010 Aug |
Date Detail:
|
Created Date: 2010-09-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 101518173 Medline TA: J Clin Aesthet Dermatol Country: United States |
Other Details:
|
Languages: eng Pagination: 27-33 Citation Subset: - |
Affiliation:
|
Skin Institute of New Orleans, New Orleans, Louisiana; Clinical Associate Professor, Department of Dermatology, Tulane University, New Orleans, Louisiana. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: A practical approach to monitoring patients on biological agents for the treatment of psoriasis.
Next Document: A Second Case of Sunitinib-associated Pyoderma Gangrenosum.